M

Marker Therapeutics
D

MRKR

1.60000
USD
0.04
(2.43%)
مغلق
حجم التداول
308
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
18,103,736
أصول ذات صلة
MRNA
MRNA
0.195
(0.64%)
30.480 USD
S
SDGR
0.140
(0.67%)
21.090 USD
المزيد
الأخبار المقالات

العنوان: Marker Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.